1. Conway J Nathan D Benz E Key learning from the Dana-Farber Cancer Institute's 10-year patient safety journey 2004
2. Criteria for facilities and personnel for the administration of parenteral systemic antineoplastic therapy. Adopted on March 3, 2004 by the American Society of Clinical Oncology;American Society of Clinical Oncology;J Clin Oncol,2004
3. ASHP guidelines on preventing medication errors with antineoplastic agents;American Society of Health System Pharmacists;Am J Health Syst Pharm,2002
4. Smith J Report of the Chief Pharmaceutical Officer Department of Health. Building a safer NHS for patients: sub section cytotoxic chemotherapy 2003 http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4071443
5. Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains;Womer;J Clin Oncol,2002